Loading…
Based on limited metadata, this FDA Warning Letter issued to Kratom Spot on May 18, 2018, concerns the company's marketing or manufacturing practices related to kratom products. Without access to the full letter text or detailed subject information, the specific violations cannot be definitively characterized, though FDA warnings to kratom vendors typically involve unapproved health claims or regulatory compliance issues. The warning was issued by the FDA's Office of Regulatory Affairs, though the specific district office is not identified in the available metadata. Additional details about the exact nature and scope of violations would require review of the complete warning letter.